Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases
AbstractBackground. Activating mutations in the pathway of phosphatidylinositol-3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) occur in 43-70% of bre
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
07 June 2019
|
| In: |
Neuro-Oncology
Year: 2019, Volume: 21, Issue: 11, Pages: 1401-1411 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noz105 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1093/neuonc/noz105 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/21/11/1401/5512506 
|
| Author Notes: | Franziska Maria Ippen, Julia Katharina Grosch, Megha Subramanian, Benjamin Macfarlane Kuter, Bianca M. Liederer, Emile G. Plise, Joana Liliana Mora, Naema Nayyar, Stephen Paul Schmidt, Anita Giobbie-Hurder, Maria Martinez-Lage, Scott L. Carter, Daniel P. Cahill, Hiroaki Wakimoto, and Priscilla Kaliopi Brastianos |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1688918345 | ||
| 003 | DE-627 | ||
| 005 | 20220817220215.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200130s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/noz105 |2 doi | |
| 035 | |a (DE-627)1688918345 | ||
| 035 | |a (DE-599)KXP1688918345 | ||
| 035 | |a (OCoLC)1341299948 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ippen, Franziska M. |d 1988- |e VerfasserIn |0 (DE-588)1093609540 |0 (DE-627)853809771 |0 (DE-576)462741524 |4 aut | |
| 245 | 1 | 0 | |a Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases |c Franziska Maria Ippen, Julia Katharina Grosch, Megha Subramanian, Benjamin Macfarlane Kuter, Bianca M. Liederer, Emile G. Plise, Joana Liliana Mora, Naema Nayyar, Stephen Paul Schmidt, Anita Giobbie-Hurder, Maria Martinez-Lage, Scott L. Carter, Daniel P. Cahill, Hiroaki Wakimoto, and Priscilla Kaliopi Brastianos |
| 246 | 3 | 0 | |a three |
| 264 | 1 | |c 07 June 2019 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.01.2020 | ||
| 520 | |a AbstractBackground. Activating mutations in the pathway of phosphatidylinositol-3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) occur in 43-70% of bre | ||
| 700 | 1 | |a Grosch, Julia Katharina |e VerfasserIn |0 (DE-588)1203890036 |0 (DE-627)1688995331 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 21(2019), 11, Seite 1401-1411 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases |
| 773 | 1 | 8 | |g volume:21 |g year:2019 |g number:11 |g pages:1401-1411 |g extent:11 |a Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases |
| 856 | 4 | 0 | |u https://doi.org/10.1093/neuonc/noz105 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/neuro-oncology/article/21/11/1401/5512506 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200130 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 1203890036 |a Grosch, Julia Katharina |m 1203890036:Grosch, Julia Katharina |d 50000 |e 50000PG1203890036 |k 0/50000/ |p 2 | ||
| 998 | |g 1093609540 |a Ippen, Franziska M. |m 1093609540:Ippen, Franziska M. |d 910000 |d 911100 |e 910000PI1093609540 |e 911100PI1093609540 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1688918345 |e 3583397126 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Franziska M.","family":"Ippen","role":"aut","display":"Ippen, Franziska M."},{"given":"Julia Katharina","family":"Grosch","role":"aut","display":"Grosch, Julia Katharina"}],"note":["Gesehen am 30.01.2020"],"language":["eng"],"name":{"displayForm":["Franziska Maria Ippen, Julia Katharina Grosch, Megha Subramanian, Benjamin Macfarlane Kuter, Bianca M. Liederer, Emile G. Plise, Joana Liliana Mora, Naema Nayyar, Stephen Paul Schmidt, Anita Giobbie-Hurder, Maria Martinez-Lage, Scott L. Carter, Daniel P. Cahill, Hiroaki Wakimoto, and Priscilla Kaliopi Brastianos"]},"origin":[{"dateIssuedDisp":"07 June 2019","dateIssuedKey":"2019"}],"recId":"1688918345","id":{"eki":["1688918345"],"doi":["10.1093/neuonc/noz105"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"11 S."}],"title":[{"title_sort":"Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases","title":"Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases"}],"relHost":[{"language":["eng"],"note":["Gesehen am 21.07.23"],"pubHistory":["1.1999 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"zdb":["2094060-9"],"eki":["357167341"],"issn":["1523-5866"]},"recId":"357167341","origin":[{"dateIssuedDisp":"1999-","publisherPlace":"Oxford ; Durham, NC","dateIssuedKey":"1999","publisher":"Oxford Univ. Press ; Duke University Medical Center"}],"disp":"Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastasesNeuro-Oncology","title":[{"subtitle":"official journal of the World Federation of Neuro-Oncology","title_sort":"Neuro-Oncology","title":"Neuro-Oncology"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"volume":"21","text":"21(2019), 11, Seite 1401-1411","issue":"11","year":"2019","pages":"1401-1411","extent":"11"}}]} | ||
| SRT | |a IPPENFRANZTARGETINGT0720 | ||